SMTL ID : 5v5n.1

Crystal structure of Takinib bound to TAK1

Coordinates

PDB Format Compare

Method

X-RAY DIFFRACTION 2.01 Å

Oligo State

monomer

Ligands

1 x EDH: N~1~-(1-propyl-1,3-dihydro-2H-benzimidazol-2-ylidene)benzene-1,3-dicarboxamide(Non-covalent)

EDH.1: 20 residues within 4Å: Chain A: V.16, G.17, R.18, G.19, A.20, V.24, A.35, K.37, V.64, M.78, E.79, Y.80, A.81, E.82, G.84, S.85, P.134, L.137, C.148, D.149 9 PLIP interactions: 9 interactions with chain A Hydrophobic interactions: A:A.35, A:M.78, A:L.137 Hydrogen bonds: A:K.37, A:A.81, A:A.81, A:D.149, A:D.149 Water bridges: A:A.20

Links

RCSB   PDBe   PDBe-KB   PDBj   PDBsum   CATH   PLIP

Citation

Totzke, J. et al., Takinib, a Selective TAK1 Inhibitor, Broadens the Therapeutic Efficacy of TNF-alpha Inhibition for Cancer and Autoimmune Disease. Cell Chem Biol (2017)

Release Date

2017-08-30

Peptides

Mitogen-activated protein kinase kinase kinase 7/TGF-beta-activated kinase 1 and MAP3K7-binding protein 1 chimera: A

SMTL:PDB

SMTL Chain Id:
PDB Chain Id:

A
A

Mitogen-activated protein kinase kinase kinase 7/TGF-beta-activated kinase 1 and MAP3K7-binding protein 1 chimera

Related Entries With Identical Sequence